NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT04704258

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
AorticLab Srl (from the registry)
Registry
  • NCT NCT04704258
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04704258. Allocation not applicable; no masking; primary purpose other. Start 2021-05-03 (actual); primary completion 2023-06-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device
Acronym
NAUTILUS
Condition
Aortic Valve Stenosis
Condition
Intracranial Embolism and Thrombosis
Intervention (Procedure)
TAVI (Transcatheter Aortic Valve Implant)
Intervention (Device)
FLOWer Embolic Protection System
Lead sponsor
AorticLab Srl (class: industry)
Collaborator
Meditrial Europe Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04704258
Content hash
0135014eac3491296a5ac848fd427129c0014a55dd39b7dc9742edcf387b026c